Dyadic International Revenue and Competitors
Estimated Revenue & Valuation
- Dyadic International's estimated annual revenue is currently $3.5M per year.
- Dyadic International's estimated revenue per employee is $83,333
- Dyadic International's total funding is $2M.
Employee Data
- Dyadic International has 42 Employees.
- Dyadic International grew their employee count by 0% last year.
Dyadic International's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO & President | Reveal Email/Phone |
2 | CFO | Reveal Email/Phone |
3 | EVP Business Development | Reveal Email/Phone |
4 | VP Research and Business Development | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | Accounting Manager | Reveal Email/Phone |
7 | Staff Accountant | Reveal Email/Phone |
8 | Staff Accountant | Reveal Email/Phone |
Dyadic International Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $15.3M | 99 | 5% | N/A | N/A |
#2 | $1.1M | 7 | -30% | N/A | N/A |
#3 | $3.7M | 24 | 4% | N/A | N/A |
#4 | $4.3M | 28 | -3% | N/A | N/A |
#5 | $2.5M | 16 | N/A | N/A | N/A |
#6 | $0.8M | 5 | 0% | N/A | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $2.5M | 16 | 7% | N/A | N/A |
#9 | $1.4M | 9 | -25% | N/A | N/A |
#10 | $0.6M | 4 | 0% | N/A | N/A |
What Is Dyadic International?
Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms - including humans - found in the earth’s biodiversity.
keywords:N/A
$2M
Total Funding
42
Number of Employees
$3.5M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Dyadic International News
JUPITER, Fla., April 28, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Dyadic, we, us, our, or the Company) (NASDAQ: DYAI),...
Dyadic International, Inc. is a global biotechnology company which is developing what it believes will be a potentially significant...
Dyadic International, Inc. (NASDAQ:DYAI) Expected to Announce Quarterly Sales of $2.37 Million. Posted by admin on Apr 22nd, 2022.
DYADIC AND SORRENTO ANNOUNCE BINDING TERM SHEET TO LICENSE DYADIC'S LEAD COVID-19 VACCINE CANDIDATE 'DYAI-100' AND C1 TECHNOLOGY FOR PROTEIN-BASED CORONAVIRUS VACCINES AND THERAPEUTICS ● Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including Gr ...
DYADIC ANNOUNCES TECHNOLOGY TRANSFER AND LICENSINGAGREEMENT WITH SOUTH AFRICA'S RUBIC CONSORTIUM AIMING TO DEVELOP AND COMMERCIALIZE VACCINES FOR DISTRIBUTION THROUGHOUT THE AFRICAN CONTINENT POTENTIAL FOR AFFORDABLE COVID-19 IMMUNIZATION COVERAGE IN UNDERSERVED AFRICAN COUNTRIES ● Arrangemen ...
Other Companies in Jupiter
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.1M | 42 | 8% | N/A |
#2 | $7.1M | 43 | 2% | N/A |
#3 | N/A | 43 | 8% | N/A |
#4 | $3.5M | 44 | 10% | N/A |
#5 | $15M | 44 | -6% | N/A |